Ligand structure-dependent differences in activation of estrogen receptor α in human HepG2 liver and U2 osteogenic cancer cell lines
- 25 April 2000
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 162 (1-2) , 211-220
- https://doi.org/10.1016/s0303-7207(99)00261-0
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Differential Interaction of the Methoxychlor Metabolite 2,2-Bis-(p-Hydroxyphenyl)-1,1,1-Trichloroethane with Estrogen Receptors α and β1Endocrinology, 1999
- Rapid screening of environmental chemicals for estrogen receptor binding capacity.Environmental Health Perspectives, 1998
- Selective Estrogen Receptor Modulators: An Alternative to Hormone Replacement TherapyExperimental Biology and Medicine, 1998
- Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptorProceedings of the National Academy of Sciences, 1997
- Evaluation of Chemicals with Endocrine Modulating Activity in a Yeast-Based Steroid Hormone Receptor Gene Transcription AssayToxicology and Applied Pharmacology, 1997
- Steroid hormone receptors: Many Actors in search of a plotCell, 1995
- Medical hypothesis: xenoestrogens as preventable causes of breast cancer.Environmental Health Perspectives, 1993
- Developmental effects of endocrine-disrupting chemicals in wildlife and humans.Environmental Health Perspectives, 1993
- Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation.Journal of Clinical Investigation, 1992
- The Steroid and Thyroid Hormone Receptor SuperfamilyScience, 1988